Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 3
1997 1
1998 1
1999 1
2000 2
2001 3
2003 2
2004 2
2005 1
2006 1
2007 1
2008 1
2009 1
2011 1
2012 3
2013 1
2016 1
2017 2
2020 1
2021 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Scleroderma mimics - Clinical features and management.
Orteu CH, Ong VH, Denton CP. Orteu CH, et al. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101489. doi: 10.1016/j.berh.2020.101489. Epub 2020 Mar 5. Best Pract Res Clin Rheumatol. 2020. PMID: 32147386 Review.
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022.
Foeldvari I, Torok KS, Antón J, Blakley M, Constantin T, Cutolo M, Denton CP, Fligelstone K, Hinrichs B, Li SC, Maillard S, Marrani E, Moinzadeh P, Orteu CH, Pain CE, Pauling JD, Pilkington C, Rosser F, Smith V, Furst DF. Foeldvari I, et al. Among authors: orteu ch. Expert Rev Clin Immunol. 2024 Apr;20(4):387-404. doi: 10.1080/1744666X.2023.2298354. Epub 2024 Jan 2. Expert Rev Clin Immunol. 2024. PMID: 38149621 Review.
Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M, Morrone A, Cardinali G, Kovacs D, Aspite N, Linder D, Parini R, Feliciani C; Interdisciplinary Study Group on Fabry Disease (ISGF). Zampetti A, et al. Among authors: orteu ch. Br J Dermatol. 2012 Apr;166(4):712-20. doi: 10.1111/j.1365-2133.2012.10742.x. Br J Dermatol. 2012. PMID: 22452439 Review.
Pseudoacromegalic facial features in Fabry disease.
Hogarth V, Hughes D, Orteu CH. Hogarth V, et al. Among authors: orteu ch. Clin Exp Dermatol. 2013 Mar;38(2):137-9. doi: 10.1111/j.1365-2230.2012.04420.x. Epub 2012 Jun 25. Clin Exp Dermatol. 2013. PMID: 22731890
British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021.
O'Kane D, McCourt C, Meggitt S, D'Cruz DP, Orteu CH, Benton E, Wahie S, Utton S, Hashme M, Mohd Mustapa MF, Exton LS; British Association of Dermatologists’ Clinical Standards Unit. O'Kane D, et al. Among authors: orteu ch. Br J Dermatol. 2021 Dec;185(6):1112-1123. doi: 10.1111/bjd.20597. Epub 2021 Oct 19. Br J Dermatol. 2021. PMID: 34170012 No abstract available.
Case 3. Fabry disease.
Eisman S, Mehta A, Orteu CH. Eisman S, et al. Among authors: orteu ch. Clin Exp Dermatol. 2003 Sep;28(5):569-70. doi: 10.1046/j.1365-2230.2003.01340.x. Clin Exp Dermatol. 2003. PMID: 12950364 No abstract available.
35 results